Correlates Of Medication Error In Hospitals
Contents |
& Bioassays Resources...DNA & RNABLAST (Basic Local Alignment Search Tool)BLAST (Stand-alone)E-UtilitiesGenBankGenBank: BankItGenBank: SequinGenBank: tbl2asnGenome WorkbenchInfluenza VirusNucleotide medication error rates in hospitals DatabasePopSetPrimer-BLASTProSplignReference Sequence (RefSeq)RefSeqGeneSequence Read Archive (SRA)SplignTrace ArchiveUniGeneAll DNA medication error in hospital setting & RNA Resources...Data & SoftwareBLAST (Basic Local Alignment Search Tool)BLAST (Stand-alone)Cn3DConserved Domain hospital medication error statistics Search Service (CD Search)E-UtilitiesGenBank: BankItGenBank: SequinGenBank: tbl2asnGenome ProtMapGenome WorkbenchPrimer-BLASTProSplignPubChem Structure SearchSNP Submission ToolSplignVector Alignment Search Tool (VAST)All Data &
Hospital Medication Error Statistics 2013
Software Resources...Domains & StructuresBioSystemsCn3DConserved Domain Database (CDD)Conserved Domain Search Service (CD Search)Structure (Molecular Modeling Database)Vector Alignment Search Tool (VAST)All Domains & Structures Resources...Genes & ExpressionBioSystemsDatabase of Genotypes and Phenotypes (dbGaP)E-UtilitiesGeneGene Expression Omnibus (GEO) Database Gene Expression Omnibus (GEO) DatasetsGene Expression hospital medication error statistics 2014 Omnibus (GEO) ProfilesGenome WorkbenchHomoloGeneMap ViewerOnline Mendelian Inheritance in Man (OMIM)RefSeqGeneUniGeneAll Genes & Expression Resources...Genetics & MedicineBookshelfDatabase of Genotypes and Phenotypes (dbGaP)Genetic Testing RegistryInfluenza VirusMap ViewerOnline Mendelian Inheritance in Man (OMIM)PubMedPubMed Central (PMC)PubMed Clinical QueriesRefSeqGeneAll Genetics & Medicine Resources...Genomes & MapsDatabase of Genomic Structural Variation (dbVar)GenBank: tbl2asnGenomeGenome ProjectGenome ProtMapGenome WorkbenchInfluenza VirusMap ViewerNucleotide DatabasePopSetProSplignSequence Read Archive (SRA)SplignTrace ArchiveAll Genomes & Maps Resources...HomologyBLAST (Basic Local Alignment Search Tool)BLAST (Stand-alone)BLAST Link (BLink)Conserved Domain Database (CDD)Conserved Domain Search Service (CD Search)Genome ProtMapHomoloGeneProtein ClustersAll Homology Resources...LiteratureBookshelfE-UtilitiesJournals in NCBI DatabasesMeSH DatabaseNCBI HandbookNCBI Help ManualNCBI NewsPubMedPubMed Central (PMC)PubMed Clinical QueriesPubMed HealthAll Literature Resources...ProteinsBioSystemsBLAST (Basic Local Alignment Search Tool)BLAST (Stand-alone)BLAST Link (BLink)Conserved Domain Database (CDD)Conserved Domain Search Service (CD Search)E-UtilitiesProSplignProtein ClustersProtein DatabaseReference Sequence (RefSeq)All Proteins Resources...Sequence AnalysisBLAS
van GoogleInloggenVerborgen veldenBoekenbooks.google.nl - The detection and evaluation of adverse drug reactions is crucial for understanding the safety of medicines and for preventing harm in patients. Not only is it necessary to detect new adverse drug reactions, but the principles and practice of pharmacovigilance apply to the surveillance of a wide range...https://books.google.nl/books/about/Stephens_Detection_and_Evaluation_of_Adv.html?hl=nl&id=Rc0H8P1XzvUC&utm_source=gb-gplus-shareStephens' Detection and Evaluation of Adverse Drug ReactionsMijn bibliotheekHelpGeavanceerd zoeken naar boekeneBoek bekijkenDit boek in gedrukte vorm bestellenWiley.comBol.comProxis.nlselexyz.nlVan StockumZoeken in een http://www.ncbi.nlm.nih.gov/pubmed/18642515 bibliotheekAlle verkopers»Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and PracticeJohn Talbot, Jeffrey K. Aronson, M. D. B. StephensJohn Wiley & Sons, 19 dec. 2011 - 732 pagina's 0 Recensieshttps://books.google.nl/books/about/Stephens_Detection_and_Evaluation_of_Adv.html?hl=nl&id=Rc0H8P1XzvUCThe detection and evaluation of adverse drug reactions is crucial for understanding the safety of medicines and for preventing https://books.google.com/books?id=Rc0H8P1XzvUC&pg=PT124&lpg=PT124&dq=correlates+of+medication+error+in+hospitals&source=bl&ots=01_G5Jyc-q&sig=FdlKo0_vAAoWOX_8kTTA5hQtAbk&hl=en&sa=X&ved=0ahUKEwjfpbnHtrzPAhUM-2MKHck0C38Q6 harm in patients. Not only is it necessary to detect new adverse drug reactions, but the principles and practice of pharmacovigilance apply to the surveillance of a wide range of medicinal products. Stephens' Detection and Evaluation of Adverse Drug Reactions provides a comprehensive review of all aspects of adverse drug reactions throughout the life cycle of a medicine, from toxicology and clinical trials through to pharmacovigilance, risk management, and legal and regulatory requirements. It also covers the safety of biotherapeutics and vaccines and includes new chapters on pharmacogenetics, proactive risk management, societal considerations, and the safety of drugs used in oncology and herbal medicines. This sixth edition of the classic text on drug safety is an authoritative reference text for all those who work in pharmacovigilance or have an interest in adverse drug reactions, whether in regulatory authorities, pharmaceutical companies, or academia. Praise for p
Research Article Open Access Medication Errors by Nurses in Sweden-Classification and Contributing factors Monica Bergqvist1*, Eva Andersén Karlsson2, Karin Sparring Björkstén3 and Johanna http://www.omicsonline.org/scientific-reports/srep527.php Ulfvarson4 1Karolinska Institute, Department of Neurobiology, Care Sciences and Society, Division of Nursing, Huddinge, http://www.cmaj.ca/content/178/13/1648.full Sweden 2Associate Professor, Karolinska Institutet, Department of Clinical Science and Education, Södersjukhuset 3Karolinska Institutet, Department of Neurobiology, Care Sciences and Society, Psychiatry South Stockholm 4Associate Professor, Karolinska Institutet, Department of Neurobiology, Care Sciences and Society *Corresponding author: Monica Bergqvist, RN, PhD Lecturer, Karolinska Institute Department of Neurobiology Care Sciences and Society Division of Nursing medication error Alfred Nobel Alle 23 PO Box 23300 14183 Huddinge, Sweden Tel: 08-52488033 E-mail: Monica.Bergqvist@ki.se Received August 20, 2012; Published September 29, 2012 Citation: Bergqvist M, Karlsson EA, Björkstén KS, Ulfvarson J (2012) Medication Errors by Nurses in Sweden-Classification and Contributing factors. doi: 10.4172/scientificreports.527 Copyright: © 2012 Bergqvist M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits hospital medication error unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Background: Medication errors are common and can cause serious adverse effects and even death. Registered Nurses (RNs) are usually in the frontline when medication errors occur. In Sweden all health-care providers are required to report to the National Board of Health and Welfare if a patient is put at risk or injured by the health-care system. Aims and objectives: To develop taxonomy for classification of reported medication errors and factors contributing to the errors. Design: This study is a method developing study classifying reported medication errors made by nurses. Method: This was an in depth analysis of 33 reported medication errors made by RNs. Content analysis was used for categorization of the errors and the contributing factors. Results: Six main-categories of errors were identified: 1) Wrong dose, 2) Wrong drug, 3) Dose(s) missed, 4) Unauthorized or unordered drug, 5) Wrong route, 6) Drug administered despite documented allergy. Six maincategories of contributing factors on the individual levels were identified: 1) Negligence, forgetfulness or lack of attentiveness, 2) Practice beyond scope, 3) Lack of knowledge, 4) Communication errors, 5) Proper protocol n
for… Authors Advertisers CME Members Subscribers Media Reprint requests Permission requests Connect with… Email alerts Twitter RSS Facebook Mobile About CMAJ General information Staff Editorial Board Journal oversight Contact Help FAQs Sitemap Contact Feedback Search for Keyword: Submit Advanced Search CMAJ June 17, 2008 vol. 178 no. 13 doi: 10.1503/cmaj.080788 News © 2008 Canadian Medical Association For the record Wayne Kondro CMAJ  Next Section Fallen MAPLEs Persistent technical problems and “economic impediments†have sunk the over budget, overdue and overdesigned Multipurpose Applied Physics Lattice Experiment (MAPLE) reactors, long touted as the future jewel of Canadian medical isotope supply. Atomic Energy of Canada Ltd. announced May 16, 2008, that it was pulling the plug on the troubled reactors (CMAJ 2008;178[7]:813-4) and will instead seek to extend the lifetime of Canada's 51-year-old National Research Universal reactor to ensure national supply of medical isotopes. Hugh MacDiarmid, president and chief executive officer of the federal Crown corporation, cast the decision as necessary, stating that “it is no longer feasible to complete the commissioning and start-up of the reactors.†Federal Minister of Natural Resources Gary Lunn said a dozen years of redesign had failed to generate a single isotope. “The project has long been crippled by both technical and economic impediments, which remained unresolved. Among the many factors are: regulatory challenges and commercial disputes which so far have cost hundreds of millions of dollars in private and public funds; technical malfunctions that could not be resolved; and reviews conducted by the Auditor General which revealed significant concerns about the costs, the delays, and the technical issues.†As reported earlier in CMAJ, total costs to date for the MAPLEs project have easily topped $500 million (although precise outlays have never been disclosed), and the agency has been entirely perplexed by a fundamental design flaw that invariably generated unexpected positive power coefficient reactivity in operational tests. Lunn said the government has asked Atomic Energy of Canada Ltd. to seek an extension of the aging National Research Universal reactor's operating site licence beyond Oct. 31, 2011, to ensure isotope supply. That, in turn, prompted the Canadian Association of Nuclear Medi